Trial Profile
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 06 Apr 2017
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Delirium; Postoperative complications
- Focus Therapeutic Use
- Sponsors Hospira
- 23 Jul 2015 Status changed from discontinued to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
- 29 Mar 2014 New trial record